Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteers.

Thompson, G A; St Peter, J V; Heise, M A; Horowitz, Z D; Salyers, G C; Charles, T T; Brezovic, C; Russell, D A; Skare, J A; Powell, J H

Thompson, G A; St Peter, J V; Heise, M A; Horowitz, Z D; Salyers, G C; Charles, T T; Brezovic, C; Russell, D A; Skare, J A; Powell, J H.

Affiliation

Thompson GA; Procter & Gamble Pharmaceuticals, Cincinnati, OH 45242, USA.

J Pharm Sci ; 85(11): 1242-7, 1996 Nov.

Article in En | MEDLINE | ID: mdl-8923333

Subject(s)

Doxylamine/pharmacology; Mixed Function Oxygenases/drug effects; Administration, Oral; Adult; Doxylamine/administration & dosage; Doxylamine/pharmacokinetics; Humans; Male; Mixed Function Oxygenases/metabolism; Placebos; Reference Values

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxylamine / Mixed Function Oxygenases Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: J Pharm Sci Year: 1996 Document type: Article

Search on Google

XML

PubMed Links